An Open-label, Multicenter, Single-arm Clinical Study on the Use of Doxorubicin Liposome in Combination With CapOX and Bevacizumab Regimen for First-line Treatment of Advanced Colorectal Adenocarcinoma With SMAD4R361H/C Mutation.
Clinical trial NCT06753721 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06753721
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-31
- Primary completion
- 2026-06-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.